Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Unclassified
The risk profile of Mescalin has not been fully characterised. Insufficient scientific data is available to draw definitive conclusions.
Aggregated from 3 verified experience reports. Community data reflects reported subjective experiences, not clinical outcomes.
The following substances carry an elevated risk of adverse interactions with Mescalin. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
Route of administration significantly influences the risk profile. Intravenous and inhalation routes carry substantially higher risks than oral administration. Commonly reported routes for Mescalin:
general
Übelkeit einplanen: Ausgeprägte Übelkeit in den ersten 1–2 Stunden ist fast unvermeidbar. Nüchtern bleiben (6–8 h) und Ingwertee kann helfen.
general
Dosierung: Reine Mescalinhydrochlorid-Dosen liegen bei 200–400 mg. Peyote- und San-Pedro-Zubereitungen variieren stark in Konzentration.
general
Sehr lange Dauer: 8–12 Stunden Gesamtdauer einplanen. Ganzen Tag/Nacht freihalten.
general
Set und Setting: Nur in sicherer, vertrauter Umgebung. Die Länge der Erfahrung macht Setting besonders wichtig.
general
Nicht bei psychischen Vorerkrankungen: Wie alle Psychedelika nicht geeignet für Personen mit Psychose-Vorgeschichte.
general
Niemals mit Lithium oder MAO-Hemmern kombinieren.
Based on 3 verified experience reports.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.